AI in Clinical Decision Support Market Size, Share and Trends Forecast, 2026-2033 | EHR Adoption and Value-Based Care Fuel 17.1% CAGR to USD 4.5 Billion
EHR integration, value-based care, and AI-CDSS workflow automation drive adoption by improving decisions, reducing risk, and optimizing clinical resources
Dublin, Nov. 13, 2026 (GLOBE NEWSWIRE) -- "Artificial Intelligence In Clinical Decision Support Market Size, Share & Trends Analysis Report by Component, Application, Deployment Mode, End Use, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global artificial intelligence in clinical decision support market was valued at approximately USD 1.3 billion in 2025 and is projected to reach USD 4.5 billion by 2033. The market is expected to expand at a compound annual growth rate of 17.1% from 2026 to 2033, supported by the increasing adoption of Electronic Health Records (EHRs), the transition toward value-based care, and growing pressure to improve clinical workflow efficiency.
Electronic Health Records Strengthen AI-CDSS Adoption
Widespread EHR adoption provides the data infrastructure required for artificial intelligence in clinical decision support systems. Healthcare organizations across the U.S., Europe, and parts of Asia-Pacific have achieved high EHR penetration, aided by regulatory mandates, government incentives, and broader digital health investments.
Access to longitudinal patient records, including medical histories, laboratory results, imaging data, and medication profiles, allows AI-CDSS platforms to generate timely and clinically relevant recommendations. Integrating these capabilities into EHR workflows supports decision-making at the point of care while helping providers improve diagnostic accuracy, treatment selection, and patient monitoring.
Oracle's EHR-integrated clinical decision support prototype demonstrates this potential by using Oracle Cloud Infrastructure (OCI) AI Vision to analyze patient images for skin cancer detection. Continued development of interoperable EHR and AI platforms is expected to accelerate the use of data-driven clinical recommendations across healthcare settings.
Value-Based Care Creates New Growth Opportunities
The shift toward value-based care is increasing demand for AI clinical decision support solutions that can improve outcomes, strengthen care coordination, and control costs. By analyzing real-time and historical patient information, AI-CDSS platforms can identify high-risk patients, estimate readmission risk, and support earlier interventions.
Integration with EHRs and population health management platforms also enables healthcare providers to monitor outcomes, improve adherence to clinical guidelines, and allocate resources more effectively. These capabilities are particularly important for chronic disease management and other areas that require continuous monitoring and timely adjustments to care plans.
A BMJ study published in March 2026 evaluated an AI-powered clinical decision support system across 40 Chinese hospitals. The study randomized 21,603 patients with acute ischemic stroke to AI-assisted or standard care. Using demographic, imaging, laboratory, and vital-sign data, the system generated tailored guideline recommendations. Results indicated fewer new vascular events at three months, improved stroke care quality, and lower long-term vascular event rates among patients receiving AI-supported care.
Clinical Workflow Efficiency Drives Implementation
Rising patient volumes, workforce shortages, and administrative demands are intensifying the need for more efficient clinical workflows. AI in clinical decision support can automate routine processes, improve access to relevant patient information, and embed evidence-based recommendations within existing systems. These functions can reduce time spent on documentation and data retrieval while allowing clinicians to focus more directly on patient care.
AI-CDSS platforms also support interdisciplinary coordination by standardizing workflows and providing unified access to patient data and actionable insights. Predictive analytics can assist with scheduling, patient triage, resource allocation, and capacity planning, helping healthcare organizations minimize delays and improve the use of clinical assets.
In April 2026, Abridge partnered with Wolters Kluwer's UpToDate to expand AI clinical decision support within its ambient documentation platform. The integration gives clinicians access to real-time, evidence-based recommendations derived from patient conversations and clinical notes across pre-, intra-, and post-encounter workflows.
Market Segmentation and Regional Coverage
The report provides revenue forecasts and trend analysis for the global artificial intelligence in clinical decision support market from 2021 to 2033. Market segmentation covers the following categories:
- Component: Software and services
- Application: Diagnostic decision support, therapeutic decision support, medication management, clinical workflow optimization, predictive analytics & risk assessment, and other applications
- Deployment mode: Web & cloud-based and on-premise
- End use: Hospitals, physician practices & ambulatory clinics, pharmaceutical & biotech companies, payers, and other end users
Regional analysis covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Country-level coverage includes the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.
As healthcare systems increase investments in digital infrastructure, interoperability, predictive analytics, and evidence-based care, the artificial intelligence in clinical decision support market is positioned for sustained growth through 2033.
Key Attributes:
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Forecast Period | 2025-2033 |
| Estimated Market Value (USD) in 2025 | $1.3 Billion |
| Forecasted Market Value (USD) by 2033 | $4.5 Billion |
| Compound Annual Growth Rate | 17.1% |
| Regions Covered | Global |
Companies Featured
- UpToDate, Inc. (Wolters Kluwer)
- Siemens Healthcare Private Limited
- GE Healthcare
- Royal Philips NV
- Premier Inc.
- Natus
- PERSYST DEVELOPMENT LLC
- Oracle
- Aidoc
- Viz.ai
- Merative
- Etiometry
For more information about this report visit https://www.researchandmarkets.com/r/ojcrlm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
